Caffeine to prevent intermittent hypoxaemia in late preterm infants: randomised controlled dosage trial

OBJECTIVE: To establish the most effective and best tolerated dose of caffeine citrate for the prevention of intermittent hypoxaemia (IH) in late preterm infants. DESIGN: Phase IIB, double-blind, five-arm, parallel, randomised controlled trial. SETTING: Neonatal units and postnatal wards of two tert...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliphant, Elizabeth Anne, McKinlay, Christopher JD, McNamara, David, Cavadino, Alana, Alsweiler, Jane M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985705/
https://www.ncbi.nlm.nih.gov/pubmed/36038256
http://dx.doi.org/10.1136/archdischild-2022-324010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985705/
https://www.ncbi.nlm.nih.gov/pubmed/36038256
http://dx.doi.org/10.1136/archdischild-2022-324010

Ejemplares similares